"Amphotericin B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
| Descriptor ID |
D000666
|
| MeSH Number(s) |
D02.540.576.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amphotericin B".
Below are MeSH descriptors whose meaning is more specific than "Amphotericin B".
This graph shows the total number of publications written about "Amphotericin B" by people in this website by year, and whether "Amphotericin B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amphotericin B" by people in Profiles.
-
Central nervous system histoplasmosis: Multicenter retrospective study on clinical features, diagnostic approach and outcome of treatment. Medicine (Baltimore). 2018 03; 97(13):e0245.
-
Fabrication of 3-O-sn-Phosphatidyl-L-serine Anchored PLGA Nanoparticle Bearing Amphotericin B for Macrophage Targeting. Pharm Res. 2018 Feb 09; 35(3):60.
-
Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol. 2017 Dec; 105(Pt 1):1220-1231.
-
Candida auris candidaemia in Indian ICUs: analysis of risk factors. J Antimicrob Chemother. 2017 06 01; 72(6):1794-1801.
-
Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis. Pharm Res. 2016 11; 33(11):2617-29.
-
Immunological Consequences of Intestinal Fungal Dysbiosis. Cell Host Microbe. 2016 Jun 08; 19(6):865-73.
-
Treatment for a eumycetoma infection caused by Aspergillus in an immunocompromised host: a case report. Transpl Infect Dis. 2015 Feb; 17(1):94-7.
-
Pseudohyperphosphatemia in children treated with liposomal amphotericin B. Am J Health Syst Pharm. 2014 Sep 01; 71(17):1462-8.
-
Histoplasma capsulatum endocarditis: multicenter case series with review of current diagnostic techniques and treatment. Medicine (Baltimore). 2014 Jul; 93(5):186-193.
-
Small-molecule suppressors of Candida albicans biofilm formation synergistically enhance the antifungal activity of amphotericin B against clinical Candida isolates. ACS Chem Biol. 2013 Apr 19; 8(4):840-8.